A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis

NCT03895203 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

852

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriatic Arthritis

Interventions

DRUG: Bimekizumab
DRUG: Adalimumab
OTHER: Placebo

Sponsor

UCB Biopharma SRL